Cure My Disease

Don't miss your cure!

 Log in / Sign up

A Baby's fidgets may reveal brain health: study tests early warning signs

NCT ID NCT06278961

Knowledge-focused Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 03, 2026 · Last updated Sep 04, 2026 · Updated 1 time

Summary

Researchers are studying the natural fidgety movements of infants to see if these movements can help predict cerebral palsy and other developmental issues. They will follow 350 babies, including healthy full-term infants and those at higher risk due to medical conditions, tracking their movements over time. The goal is to find the best time to use this movement assessment for accurate early detection. This could lead to earlier support for children who need it.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Observation of infant movement patterns through video recordings and neurodevelopmental assessments
What this could lead to
If successful, this could lead to more accurate early detection of cerebral palsy and other neurodevelopmental impairments, enabling earlier intervention and support.
What could go wrong
This is an observational study, so it will not test a treatment. The findings depend on the accuracy of movement assessments and may not apply to all infants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 350 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2021

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Infants aged 10-20 weeks adjusted age. Not of other target special populations.

Ages

10 to 20 weeks

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Infants born full-term with typical development, bithweight \>2500g * Infants with a history of brochopulmonary dysplasia, defined as having a preterm birth (\<33 weeks gestational age) and requiring supplemental oxygen beyond 36 weeks gestational age * Infants with neonatal encephalopathy, who required hypothermic cooling treatment * Infants born \<36 weeks gestational age * Infants born in a multiple gestation pregnancy * Infants with a diagnosis of Trisomy 21 * Infants born and diagnosed with SMA prenatally, via newborn screening assessment or prior to 10 weeks corrected age * Infants are less than 10 weeks corrected age at time of enrollment Exclusion Criteria: * Children who are enrolled in DCFS custody * Parent or infant guardian does not have a smartphone

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bronchopulmonary dysplasia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bronchopulmonary dysplasia cerebral palsy Motor Disorders movement disorder nervous system disorder spinal muscular atrophy trisomy 21

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cerebral palsy Infant development Motor disorders Neurological disorder

Contacts and locations

Locations

  • Feinberg School of Physical Therapy and Human Movement Sciences

    Chicago, Illinois, 60611, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.